EPHA2 and sarcoma: A different study used the ephrin type-A receptor-2 (EphA2) as a target antigen, showing that EphA2-CAR-NK-92 cells suppressed local tumor progression and metastatic burden in lungs in a sarcoma orthotopic mouse model (101).